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Abstract
Background: One of the most important functions of long noncoding RNAs (lncRNAs) is to control protein coding
gene transcription by acting locally in cis, or remotely in trans. Herpes Simplex Virus type I (HSV-1) latently infects
over 80 % of the population, its reactivation from latency usually results in productive infections in human epithelial
cells, and is responsible for the common cold sores and genital Herpes. HSV-1 productive infection leads to
profound changes in the host cells, including the host transcriptome. However, how genome wide lncRNAs
expressions are affected by the infection and how lncRNAs expression relates to protein coding gene expression
have not been analyzed.
Methods: We analyzed differentially expressed lncRNAs and their potential targets from RNA-seq data in HSV-1
infected human foreskin fibroblast (HFF) cells. Based on correlations of expression patterns of differentially
expressed protein-coding genes and lncRNAs, we predicted that these lncRNAs may regulate, either in cis or in
trans, the expression of many cellular protein-coding genes.
Results: Here we analyzed HSV-1 infection induced, differentially expressed lncRNAs and predicted their target
genes. We detected 208 annotated and 206 novel differentially expressed lncRNAs. Gene Ontology and Pathway
enrichment analyses revealed potential lncRNA targets, including genes in chromatin assembly, genes in neuronal
development and neurodegenerative diseases and genes in the immune response, such as Toll-like receptor
signaling and RIG-I-like receptor signaling pathways.
Conclusions: We found that differentially expressed lncRNAs may regulate the expression of many cellular protein-
coding genes involved in pathways from native immunity to neuronal development, thus revealing important roles
of lncRNAs in the regulation of host transcriptional programs in HSV-1 infected human cells.
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Background
Approximately 70 % of the human genome is transcribed,
but less than 2 % of which encodes proteins. The remain-
der, collectively referred to as noncoding RNAs, are one of
the most intensely investigated subjects in almost all areas
of biomedical science. Based on the size of their tran-
scripts, noncoding RNAs (ncRNAs) are classified into
small noncoding RNAs (length <200 nt) and long noncod-
ing RNAs (lncRNAs, length > 200 nt). With their number
approaching 10 thousand in the human genome [1, 2],
lncRNAs have been shown to have diverse activities, ran-
ging from recruiting chromatin remodeling complexes to
transcriptional regulation and post transcriptional
processing of RNAs [3]. LncRNAs could cooperate with
DNA, other RNAs or proteins [4] to function in cell dif-
ferentiation, development to diseases [5]. One of the best
understood lncRNAs functioning in development,
HOTAIR, is located within the HoxC gene cluster on
chromosome 12, and represses the expression of genes in
the HoxD gene cluster on chromosome 2 [6]. The most
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heavily investigated imprinted loci, IGF2/H19 encode a
lncRNA H19, and its depletion caused precocious muscle
differentiation [7]. lnc-DC, on the other hand, is a lncRNA
implicated in immune system development, its knock-
down impaired Dendritic Cell (DC) differentiation and re-
duced capacity of DCs to stimulate T cell activation [8].
LncRNA is also implicated in tumorigenesis, for example,
a lncRNA ceruloplasmin (NRCP) was highly up-regulated
in ovarian tumors, which significantly increased cancer
cell growth by altering glycolysis compared with normal
cells [9]. MALAT1 (metastasis associated lung adenocar-
cinoma transcript 1), one of the most abundant lncRNAs,
could regulate alternative splicing by modulating the
phosphorylation of the serine/arginine splicing factors
[10]. LncRNA is also implicated in pathogen-host inter-
action [11], for example, a cellular lncRNA, negative regu-
lator of antiviral response (NRAV), promoted influenza A
virus (IAV) replication and virulence.
An increasing amount of evidence suggests that
lncRNAs act either locally to regulate nearby genes in cis
or remotely, i.e. over one mega bases away or on a differ-
ent chromosome, in trans to control the transcription of
target genes [2, 4, 12, 13]. LncRNAs could directly silence
or activate gene expression, or by indirectly regulate chro-
matin states of their target genes [14]. For instance, Evf, a
cis-acting lncRNA, is required for the activation of Distal-
less homeobox (Dlx) 5 and 6 genes and generation of
GABAergic interneurons in vivo [15]. HOTAIR, on the
other hand, binds to PRC2 and LSD1 complexes and cou-
ples H3K27 methylation and H3K4 demethylation activity
to hundreds of sites genome-wide [16].
Herpes Simplex Virus type I (HSV-1) is a double strand
DNA virus, with a 152 kb genome, encoding about 80
genes, which also include several small RNAs and a
lncRNA, latency associated transcript, or LAT [17, 18].
HSV-1 reactivation can cause diseases from the mild cold
sores to the crippling encephalitis [19]. During productive
HSV-1 infection, which is responsible for these diseases,
host cells activate native antiviral immunity [20, 21], apop-
tosis [22, 23], DNA damage response and other stress re-
sponses [24–27] to limit HSV-1 infection and growth [27].
However, many viral genes are designed to modify these
responses. For example, ICP4, ICP22 and ICP27 are nega-
tive regulators of the host apoptotic response, ICP34.5 in-
hibits the type I interferon response by inactivating
protein kinase R (PKR) [28–30], while ICP8 inhibits the
host DNA damage response by inactivating the ataxia-
telangiectasia and Rad3 related (ATR) kinase [31–34].
Although the molecular details of the HSV-1 lytic infec-
tion process is well understood, many important questions
on virus-host interactions and host responses, especially
at the transcriptomic level still remain unanswered. Here
we analyzed RNA-seq data [35] of HSV-1 infected human
HFF cells for differentially expressed lncRNAs, and found
208 annotated and 206 novel lncRNAs in HSV-1 infected
cells. Using method described by Derrien et al. [2], we
found protein-coding genes (PCGs) that are either nega-
tively or positively correlated with lncRNAs expression.
These correlated lncRNAs exist both in cis and in trans
relative to their target PCGs, and are mostly involved in
chromatin assembly and metabolic process GO terms.
Pathway analysis showed that PCGs correlated with
lncRNAs in trans were enriched in B cell receptor signal-
ing pathway, Toll-like receptor signaling pathway and
RIG-I-like receptor signaling pathway. Pathway analysis of
PCGs associated with lncRNAs in cis included axon guid-
ance, focal adhesion, adherens junction and Neurotrophin
signaling pathways. Interestingly, genes in two neurodegen-
erative diseases, Huntington’s disease (HD) and Parkinson’s
disease (PD) are potentially regulated by lncRNAs, such as
PPP3CB-AS1, SNHG8 and DARS-AS1. This analyses sug-
gested important roles of lncRNAs in HSV-1 infection, and
their regulation of cellular gene transcription.
Methods
Prediction of lncRNAs
We used FastQC software to filter low quality reads with
default argument.
Clean RNA-seq data were aligned to Human reference
genome (Homo_sapiens. GRCh38) with Tophat2. Cufflinks
and Cuffcompare were used to assemble and compare tran-
scripts with reference. Then we used to custome script to
extract the length of transcript ≥ 200 nucleotides, the num-
ber of exon ≥ 2 and belonged to class code “i”, “j”, “o”, ”u”
and “x”. We used CNCI software to predict the coding cap-
acity of candidate lncRNAs. Based on Sun et al. [36], we ob-
tained high quality assemblies and used it as final reference
annotation file. We counted differentially expressed genes
with Cuffdiff2, and used the following criterion to select dif-
ferentially expressed lncRNA genes: FDR ≤ 0.05 and fold-
change ≥2 (Additional file 1: Figure S1).
Targets of lncRNAs
For gene regulation by lncRNA in cis, we extracted PCGs
located within a genomic window of 1 Mb as targets of
lncRNAs. For in trans regulation of PCGs by lncRNA, we
extracted PCGs far away with lncRNA about 1 Mb or lo-
cated in different chromosomes. Then we calculated the
correlation coefficient (r, Pearson, p value ≤ 0.05) between
the targets and lncRNAs and selected |r| ≥ 0.8 and |r| ≥ 0.9
for cis and trans, respectively (Additional file 1: Figure S1).
Gene ontology and pathway analysis
We uploaded the targets of lncRNAs into The Database for
Annotation, Visualization and Integrated Discovery
(DAVID) v6.7 to do Gene Ontology analyses (biological
processes) and Pathway analyses (KEGG pathways). DAVID
calculated a p value for gene enrichment with a modified
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Fisher’s exact test, and a Benjamin-Hochberg multiple test
correction. We selected significant GO terms and pathways
with p value ≤ 0.05.
Co-expressed modules analysis
We used STEM software to analyze co-expressed modules
of PCGs and lncRNAs, and we chose significant modules
with p value ≤ 0.05.
Statistic analysis
We used R relative packages, such as pheatmap (pheatmap:
Pretty Heatmaps, Raivo Kolde, 2015) and VennDiagram
(VennDiagram: Generate High-Resolution Venn and Euler
Plots, Hanbo Chen, 2015), and functions, such as cor.test
to analyze data and draw figures.
Results
LncRNAs expressed in HSV-1 infected HFF cells
To determine how lncRNA expression is affected by
HSV-1 infection, we analyzed RNA-seq datasets from
NCBI GEO and filtered the low quality reads using
FASTX-Toolkit (http://hannonlab.cshl.edu/fastx_toolkit/
) software, followed by aligning RNA-seq data onto hu-
man reference genome with Tophat2 [37], and subse-
quently using Cufflinks [38] and Cuffcompare [38] to
assemble and compare transcripts. In addition, we ex-
tracted the fasta sequences of candidate novel lncRNAs,
and used CNCI [39] software to distinguish noncoding
RNAs from coding RNAs. Finally, compared to Ensembl
database, we obtained 14,654 annotated lncRNAs and
3,050 novel lncRNAs consisted of 5,909 transcripts
(Additional file 1: Figure S1).
Previous studies in mammals showed that lncRNAs
are shorter in length, have fewer exons and expressed at
much lower levels than PCGs [1, 36, 40, 41]. To deter-
mine whether the novel lncRNAs we detected have the
same features, we calculated exon numbers in detected
novel lncRNAs and PCGs, and found that the exon
numbers of these novel lncRNAs are much smaller than
that of PCGs (p value < 0.05, Welch Two Sample t-test)
(Fig. 1a), and the exon length of novel lncRNAs is much
shorter than that of PCGs (p value < 0.05, Welch Two
Sample t-test) (Fig. 1b). We next calculated the expres-
sion level of PCGs and novel lncRNAs, and found that
the expression level of PCGs is much higher than that of
novel lncRNAs in all samples with the exception of 6hpi
and 8hpi samples (p value < 0.05, Welch Two Sample t-
test, Fig. 1c). The expression levels of PCGs from the
6hpi and 8hpi samples were slightly higher than that of
novel lncRNAs, which is likely due to the viral protein
VHS, which is known to degrade host mRNAs [42–46]
(p value <0.05, Welch Two Sample t-test). Thus, these
novel, de novo assembled lncRNAs are highly credible.
We then used the high quality GTF file as reference an-
notation file for further analysis.
Differentially expressed lncRNAs due to HSV-1 infection
Cuffdiff2 [47] software was used to calculate differen-
tially expressed (DE) genes from 2hpi to 8hpi samples
compared to mock infected samples.
Overall, the number of DE lncRNAs increased with
time after virus infection. For example, there was no DE
lncRNAs at 2 hours after HSV-1 infection, but there
were 15 annotated and 17 novel DE lncRNAs expressed
at 4hpi sample (Fig. 2a and b). At 6hpi sample, 74 anno-
tated and 75 novel DE lncRNAs were found, respectively
(Fig. 2a and b), while in the 8hpi sample, many more DE
lncRNAs, including 193 annotated and 197 novel
lncRNAs were observed (Fig. 2a and b). We pooled all
DE lncRNAs from 4hpi to 8hpi samples, and obtained
414 DE lncRNAs, including 208 annotated and 206
novel lncRNAs (Fig. 2a and b).
Based on methods by Derrien et al. [2], we also classi-
fied the above DE lncRNAs into five types: antisense
RNA, long intronic non coding RNA (lincRNA), proc-
essed transcript, sense intronic transcript, and sense
overlapping transcript. We found that the number of
lincRNAs was most abundant among all lncRNAs. Previ-
ous study showed the expression of lncRNAs is very cell
type and tissues specific [2], we therefore determined
the temporal specificity of lncRNAs during the course of
infection. Indeed, these lncRNA expression patterns are
highly dynamic, for example, there were only 27 over-
lapped DE lncRNAs, including 11 annotated and 16
novel lncRNAs, when compared the 4hpi with 8hpi sam-
ples (Fig. 2a and d). This dynamic nature is consistent
with their regulatory roles.
Prediction of cis target genes of virus induced DE
lncRNAs
Based on previous studies describing in cis and in trans
regulation modes to predict target PCGs and functions of
lncRNAs at transcriptomic level [2, 48], we analyzed in cis
correlation coefficient (r) of expression of lncRNAs and
PCGs. Between PCGs and lncRNAs, we obtained 928 and
1,188 pairs of positive and negative regulatory modes, re-
spectively (Fig. 3a and b).
Using DAVID [49] software, Gene Ontology (GO) ana-
lysis of DE PCGs with positive cis correlation coefficients
with lncRNAs revealed genes enrichment for metabolic
processes and neuronal differentiation GO terms (Fig. 3c).
In contrast, PCGs negatively correlated with lncRNAs were
enriched in assembly of marco molecular complexes, such
as nucleosome and chromatin assembly. For example, two
PCGs, HIST1H2AB and HIST1H2AC, which were both
significantly down-regulated about 2.5 fold after HSV-1
infection, were negatively associated with one annotated
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Fig. 1 (See legend on next page.)
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lncRNA, ZNRD1-AS1 (significantly up-regulated about 4
fold by the infection) (Fig. 3d).
Pathway (KEGG) enrichment analysis revealed 9 path-
ways for DE PCGs positively affected by lncRNAs in cis,
and 10 pathways for DE PCGs negatively affected by
lncRNAs in cis (Fig. 3e and f), which include axon guid-
ance, focal adhesion, adherens junction and Neurotrophin
signaling pathways. These pathways are involved in differ-
entiation and survival of neural cells, and higher neuronal
function, such as learning and memory [50, 51]. As HSV-1
is a neurotropic virus, the regulation of these genes in cis
by HSV-1 induced lncRNAs is of biological significance.
One of the immediate early viral protein encoded by HSV-
1, ICP0 is known to activate neuronal genes [25, 52–54],
and may contribute to the DE lncRNAs and correlated
PCGs. Interestingly, we also found PCGs with negative cor-
relation coefficients were enriched in Systemic lupus ery-
thematous, which is reported to be linked to HSV-1
infection [55].
To confirm the co-expression signature of PCGs and
lncRNAs by correlation analyses, we used STEM [56]
software to analyze co-expressed modules from the
above-mentioned expression of PCGs and lncRNAs. In









































































Fig. 2 The number of differentially expressed lncRNAs at different time points after HSV-1 infection. a There are 15, 74 and 193 annotated differentially
expressed lncRNAs in 4hpi, 6hpi and 8hpi samples, respectively. b There are 11 common annotated lncRNAs among 4hpi, 6hpi and 8hpi samples. c There
are 17, 75 and 197 differentially expressed novel lncRNAs in 4hpi, 6hpi and 8hpi samples, respectively. d 16 common novel lncRNAs are found among
4hpi, 6hpi and 8hpi samples
(See figure on previous page.)
Fig. 1 Comparisons of transcript length, exon number and expression levels of HSV-1 infected transcriptome. a Comparison of exon number. The
novel lncRNAs represent smaller the number of exon than PCGs on average. b Comparison of transcript length. The novel lncRNAs show shorter
length on average than PCGs. c The coding transcripts represent slightly higher expression level than the novel lncRNAs, but significantly higher
expression than the annotated lncRNAs. Wilcox.test, p value <0.05
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Fig. 3 The predicted function of lncRNAs regulating PCGs in cis. a 714 PCGs and 83 lncRNAs composed 918 pairs of positive in cis,, the color-axis
of heatmap is the log10
FPKM+1. The correlation coefficients (r) ≥0.8, p value≤ 0.05. b 933 and 84 lncRNAs composed 1188 negative regulatory modes
in cis. The correlation coefficients (r)≤−0.8, p value≤ 0.05. c, e. GO analysis and pathway analysis of coding genes associated with positive correlation
coefficients, p value≤ 0.05; (d, f). GO analysis and pathway analysis of PCGs associated with negative correlation coefficients, p value≤ 0.05. The x-axis
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p value
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5 and 4 specific profiles showed significant enrichment
for PCGs and lncRNAs (p value < 0.05), respectively
(Additional file 1: Figure S2A and D). GO and Pathway
enrichment analysis for these PCGs from significant co-
expressed modes (Additional file 1: Figure S2A and C, E
and F) showed that the top10 GO terms and pathways
were also enriched in chromatin assembly, metabolic
processes and neuronal differentiation, and Neurotro-
phin signaling and adherens junction, respectively. Thus,
these results are consistent with the results obtained
using correlation analysis.
Prediction of trans target genes of HSV-1 induced DE
lncRNAs
We then analyzed in trans correlations of expression
(defined as pairs consisting of lncRNAs and coding
genes separated by a distance of >1 mega base, or lo-
cated on different chromosomes), and found 2,072 and
1,803 pairs of positive and negative regulatory modes,
respectively (Fig. 4a and b).
GO analysis of genes with positive correlation coeffi-
cients enriched these genes in transcription, metabolic
processes, and development on the top 10 terms (Fig. 4c).
For example, one PCG, KDM5B, a lysine-specific histone
demethylase from the jumonji/ARID domain-containing
family with a role in the transcriptional repression [57],
was up-regulated after HSV-1 infection and showed
highly positive correlation (r > 0.9, p value < 0.01) with
one annotated lncRNA, KCNQ1OT1. KCNQ1OT1 in-
teracts with chromatin and regulates transcription of
multiple target genes through epigenetic modifications
[58]. On the other hand, the coding gene, PRKAA1, a
member of Ser/Thr protein kinase family [59], positively
associated with one novel lncRNA (location of the novel
lncRNA in genome: Chr22: 38705722–38794198), which
was up-regulated after HSV-1 infection. Again from the
imprinted IGF2/H19 loci, IGF2 [60] was up-regulated by
HSV-1 infection, and showed highly positive correlation
with one antisense lncRNA, BZRAP1-AS1. These posi-
tive correlations strongly suggest regulatory connections
between lncRNAs and correlated PCGs in chromatin
and transcriptional regulation.
Interestingly, we also found genes positively affected by
lncRNAs through in trans were enriched in B cell receptor
signaling pathway, which resulted in the expression of im-
mediate early genes that further activated the expression of
other genes involved in B cell proliferation, differentiation
and Ig production as well as other processes [61]. For ex-
ample, B-cell linker, BLNK, encodes a cytoplasmic linker or
adaptor protein that plays a critical role in B cell
development [62], was induced after HSV-1 infected HFF
cells for 6 h. It exhibited highly positive correlation (r >
0.99, p value < 0.001) with two novel lncRNAs (located at
Chr12:220425–262873 and Chr9:99297947–99319599).
Another important enriched pathway is the Toll-like recep-
tor signaling pathway [63]. For example, IRF3, which was
significantly down-regulated by HSV-1 infection, associated
with one novel lncRNA (located at Chr7: 34,928,699-
35,038,271), while IRF5 and IRF7, significantly up-regulated
after HSV-1 infected for 8 h, were positively associated with
two annotated lncRNAs, ZNRD1-AS1 and MAMDC2-
AS1, respectively. A third immunity related pathway is the
RIG-I-like receptor signaling pathway, which is responsible
for detecting viral pathogens and generating innate im-
mune responses [64, 65] (Fig. 4e). Besides immune genes,
we also found lncRNAs functioning in the DNA damage
response, for example, protein coding gene ATG5, which
was significantly down-regulated after HSV-1 infection,
showed positive association with one lncRNA, noncoding
RNA activated by DNA damage (NORAD), which is also
down-regulated after HSV-1 infection [11]. As HSV-1 in-
fection is known to activate the cellular DNA damage re-
sponse, the down regulation of NORAD could be due to
the active inhibition of one viral gene, ICP8, which inhibits
the host DNA damage response by inactivating the ATR
kinase [31–34].
In contrast, genes with negative correlation coeffi-
cients with lncRNAs were enriched in apoptosis and cell
proliferation by GO analysis (Fig. 4d), suggesting that
genes in these two processes are likely subject to inhib-
ition by virus induced lncRNAs. For example, CASP7, a
member of caspases functioning in apoptosis [66], was
down-regulated by HSV-1 infection, and showed nega-
tive correlation with three lncRNAs, PPP3CB-AS1,
SNHG8 and DARS-AS1. TGFBR2, a member of the Ser/
Thr protein kinase family and the TGFB receptor sub-
family [67], was down-regulated after HSV-1 infection
and showed highly negative correlation (r < −0.9, p value
< 0.01) with KCNQ1OT1, which can interact with chro-
matin and regulate transcription of multiple target genes
through epigenetic modifications [50].
Notably, two neurodegenerative diseases, Huntington’s
disease (HD) and Parkinson’s disease (PD) pathway
genes are negatively correlated with lncRNAs both in cis
and in trans (Fig. 3e and Fig. 4f ). HD, a neurodegenera-
tive genetic disorder, can affect muscle coordination and
lead to mental decline and behavioral symptoms [68].
Previous studies found that REST (RE1-Silencing Tran-
scription Factor) is involved in HD and is considered a
hub in the co-ordinate regulation of the transcriptome
and epigenome in HD [69, 70]. Normally, REST represses
neuronal genes in non-neuronal tissues [71], but in HSV-1
infected HFF cells, it was significantly down-regulated,
leading to up-regulation of many neuronal genes, which is
believed to be caused by HSV-1 protein ICP0 [25, 52–54].
PD is another important neurodegenerative disorder [72].
Here UCHL1 (Ubiquitin Carboxyl-Terminal Esterase L1),
a susceptibility gene for PD and a potential target for
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disease-modifying therapies [73], was significantly down-
regulated by HSV-1 infection, and a novel, HSV-1 induced
lncRNA (located at 4:68282460–68285959), negatively
correlated with REST and UCHL1, thus could potentially
inhibit the expression of REST and UCHL1. Therefore,
HSV-1 induced lncRNAs could promote neural specific
programs.
We also analyzed co-expressed modules of PCGs and
lncRNA to check whether the correlation analysis is
right, we found 8 and 6 significant co-expressed modules
for positive and negative regulation (p value < 0.05), re-
spectively (Additional file 1: Figure S3A, D). Compared
to above mentioned GO terms, this method found that
PCGs, co-expressed with lncRNAs, were also enriched
in the similar GO terms, such as metabolic processes
and development. In addition, pathway enrichment ana-
lysis revealed that many PCGs were also enriched in the
pathways detected by correlation analysis. For instance,
we found that some PCGs, such as BLNK, REST and
UCHL1, were enriched in B cell receptor signaling path-
way, HD and PD, respectively (Additional file 1: Figure
S3B and C, E and F).
Discussion and conclusions
HSV-1 is an important and ubiquitous human pathogen.
Its lytic infection in cultured cells has been used as a
paradigm to investigate the basic mechanism of tran-
scription, molecular virology and virus-host interactions.
HSV-1 infection is known to profoundly alter the host
transcriptome, from differential gene expression, to RNA
splicing and RNA Pol II read through [29, 35, 74]. The
human genome encodes around ten thousand lncRNAs
[16, 17], which are involved in many different biological
processes [3, 5]. However, how lncRNA expression is af-
fected by HSV-1 infection and whether lncRNAs play
any roles in the transcriptomic response to viral infec-
tion are not understood. Here we analyzed the HSV-1
infected transcriptome to reveal how many lncRNAs are
expressed in HFF cells and how they are affected by the
infection, and found 14,654 annotated lncRNAs, and
3,050 novel lncRNAs when compared to the Ensemble
database. Among the 3,050 newly discovered lncRNAs,
789 were induced by HSV-1 infection. Then based on
criterion (FDR ≤ 0.05 and fold-change ≥2) of differential
expression analysis, we obtained 208 annotated DE
lncRNAs, including 166 up-regulated and 42 down-
regulated lncRNAs, and 206 novel DE lncRNAs, includ-
ing 171 up-regulated and 35 down-regulated lncRNAs,
after HSV-1 infection. Similar method of predicting
novel lncRNAs was used by Sun et al. [36], in order to
avoid genome contamination in RNA-seq samples, here
we set more strict cutoff that the number of exon of
candidate novel lncRNAs is more than 1. As a result,
our prediction may have excluded some positive genes.
Next, we predicted the potential targets of the DE
lncRNAs by correlation of expression levels of PCGs and
lncRNAs. An important modus operandi of lncRNAs is to
act in cis to control the expression of PCGs that are posi-
tioned in the vicinity of their transcription sites [5]. By
correlation prediction of expression levels in cis mode, we
found many PCGs negatively associated with lncRNAs
were enriched in large marco molecular complex assem-
bly, including protein DNA complex assembly, nucleo-
some assembly and chromatin assembly, suggesting that
these lncRNAs may negatively regulate these PCGs. In
contrast, GO analysis showed that PCGs positively corre-
lated with lncRNAs were enriched in metabolic process,
differentiation and phosphorylation. These patterns of
correlations suggest that these lncRNAs might regulate
the correlated PCGs in these biological processes.
HSV-1 is well known to modulate host responses from
native immunity [29, 75] to apoptosis [17, 18] to benefit
viral transcription and replication. Pathway analysis showed
that some PCGs positively related with lncRNAs in trans
were enriched in B cell receptor signaling pathway, Toll-
like receptor signaling pathway and RIG-I-like receptor
signaling pathway. For instance, IRF5 and IRF7, positively
correlated with ZNRD1-AS1 and MAMDC2-AS1, may be
up-regulated by two lncRNAs, respectively. This analysis
suggests that lncRNA might play important roles in regulat-
ing immune response. In the list of genes that are predicted
to be in trans targets of lncRNAs, we found that PCGs
negatively associated with lncRNAs were enriched in apop-
tosis. For example, PIM2, reported to promote cell survival
and inhibit apoptosis [76], was up-regulated by HSV-1 in
HFF cells and was negatively correlated with lncRNA
DNM3OS. Meanwhile, CASP7, a member of the apoptotic
pathway [61], was down-regulated by HSV-1 infection and
showed negative correlation with PPP3CB-AS1, SNHG8
and DARS-AS1. Thus, this analysis brings forward a
hypothesis that HSV-1 might modulate the host apoptotic
pathway by targeting lncRNAs, including DNM3OS,
PPP3CB-AS1, SNHG8 and DARS-AS1.
The DNA damage response is another important cel-
lular response to HSV-1 infection. Here ATG5, which
functions as a potent molecular decoy for PUMILIO
proteins repress a program of genes necessary to
maintain genomic stability [11], was significantly down
regulated after HSV-1 infected in HFF cells. This expres-
sion pattern showed highly positive association with
NORAD [10]. HSV-1 infection induces DNA replication
stress and activates the DNA damage response [24–26].
At the same time, viral protein ICP8 inhibits the ATR
kinase activity to modulate the cellular DNA damage
response [31–34]. Thus it would be interesting to inves-
tigate whether HSV-1 actively inhibits the expression of
NORAD, for example by ICP8 to modulate host
response.
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In summary, we predicted potential target genes of
HSV-1 induced, differentially expressed lncRNAs in HFF
cells, and revealed a large number of target genes that
may participate in cellular pathway functions in response
to viral infection. Our analysis suggests that one lncRNA
might regulate many PCGs, while individual PCGs could
also be regulated by multiple lncRNAs. The two
methods we used, correlation analysis and co-expression
module analysis by and large produced similar results,
thus these potential lncRNAs target genes offer import-
ant clues to further study mechanism of viral-host inter-
action and the regulatory functions of lncRNAs.
Additional file
Additional file 1: Figure S1. Computational prediction of lncRNAs in
HSV-1 infected HFF cells. The computational strategy of predicting of
function of lncRNAs in HSV-1 infected HFF cells. Figure S2 The predicted
function of lncRNAs based on co-expressed modules in cis. a. there were 5
significant co-expressed modules in positive regulatory model, p value≤
0.05. b-c. GO analysis and pathway analysis of PCGss co-expressed with
lncRNAs, p value≤ 0.05; d. there were 4 significant co-expressed modules in
negative regulatory model, p value≤ 0.05. e-f. GO analysis and pathway
analysis of PCGs co-expressed with lncRNAs, p value≤ 0.05. Figure S3 The
predicted function of lncRNAs based on co-expressed modules in trans. a.
there were 8 significant co-expressed modules in positive regulatory
model, p value ≤ 0.05. b-c. GO analysis and pathway analysis of PCGss
co-expressed with lncRNAs, p value ≤ 0.05; d. there were 6 significant
co-expressed modules in negative regulatory model, p value ≤ 0.05. e-f.
GO analysis and pathway analysis of PCGs co-expressed with lncRNAs,
p value ≤ 0.05. (DOCX 653 kb)
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